We are live on !
Find out more
Loftus Peak Portfolio holdings
AUM
$781M
Turnover
14.29%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$781M
AUM Growth
+$46.5M
(+6.3%)
Cap. Flow
+$32M
Cap. Flow % of AUM
Cap. Flow %
4.09%
Top 10 Holdings %
Top 10 Hldgs %
60.82%
Holding
28
New
2
Increased
16
Reduced
8
Closed
2
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$17.1M |
| 2 |
BlackBerry
BB
|
+$15.8M |
| 3 |
Marvell Technology
MRVL
|
+$14.1M |
| 4 |
Broadcom
AVGO
|
+$13.2M |
| 5 |
ASML
ASML
|
+$9.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roku
ROKU
|
+$18.3M |
| 2 |
Moderna
MRNA
|
+$17.9M |
| 3 |
Advanced Micro Devices
AMD
|
+$12.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.8M |
| 5 |
Microsoft
MSFT
|
+$7.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 60.64% |
| 2 | Communication Services | 18.64% |
| 3 | Healthcare | 12.08% |
| 4 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Micron Technology
MU
$1.05T
| $8.76M | 1.12% |
8,225
-4,289
| -34% | -$4.07M |
2026 Q2
1 quarter
|
|
|
27
Moderna
MRNA
$86.8B
| – | – |
-255,836
| Closed | -$17.9M | – |
|
|
28
Roku
ROKU
$23.2B
| – | – |
-132,558
| Closed | -$18.3M | – |
|
Similar funds
QCM
Loftus Peak's Q3 2026 Portfolio in Review
As of Q3 2026, Loftus Peak held 28 positions worth $781M, up 6.3% from $734M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Loftus Peak deployed $32M of net new capital in Q3 2026, opening 2 new positions and adding to 16 existing holdings. Its largest new stake was AstraZeneca: 102,629 shares worth $16.6M.
By sector, the portfolio is most concentrated in Technology at 61% of assets, up from 58% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $12.4M trimmed.
- Loftus Peak's largest Q3 2026 buy was AstraZeneca: 102,629 shares worth $16.6M.
- Loftus Peak added most to Marvell Technology in Q3 2026, an estimated $14.1M increase.
- Loftus Peak's biggest Q3 2026 reduction was Advanced Micro Devices, cutting an estimated $12.4M.
- Loftus Peak fully exited Roku in Q3 2026, selling an estimated $18.3M.
- Loftus Peak's ten largest holdings make up 61% of its $781M portfolio in Q3 2026.
- Loftus Peak opened 2 new positions and closed 2 in Q3 2026.
- Loftus Peak's portfolio value rose 6.3% quarter-over-quarter to $781M.
Based on Loftus Peak's 13F filing for Q3 2026, filed 15 Oct 2026.